Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glendenning

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Physical Review. D, Particles and Fields|February 15, 1995
Structure and stability of strange and charm stars at finite temperaturesKettner, Weber, Weigel, et al.
Prostate Cancer and Prostatic Diseases|January 30, 2008
Sweet's syndrome in prostate cancerJ Glendenning, V Khoo
Breast (Edinburgh, Scotland)|October 22, 2011
PARP inhibitors--current status and the walk towards early breast cancerJennifer Glendenning, Andrew Tutt
The Medical Journal of Australia|April 3, 2004
8: Disorders of bone and mineral other than osteoporosisRichard L Prince, Paul Glendenning
Critical Reviews in Clinical Laboratory Sciences|September 18, 2015
Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementationPaul Glendenning, Charles A Inderjeeth
Internal Medicine Journal|January 11, 2002
Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significanceP Glendenning, S D Vasikaran
The Medical Journal of Australia|August 16, 2005
Fit for a fractureHannah M Seymour, Paul Glendenning
Pathology|July 12, 2002
Surgically correctable hypertensionPaul Glendenning, Samuel D Vasikaran
Acta Neurobiologiae Experimentalis|November 6, 1998
Lack of projections from medial geniculate body to suprasylvian cortex in cat: a study with horseradish peroxidaseM Stasiak, K K Glendenning
Internal Medicine Journal|October 11, 2012
What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?P Glendenning, R L Prince
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Physical Review. D, Particles and Fields|February 15, 1995
Structure and stability of strange and charm stars at finite temperaturesKettner, Weber, Weigel, et al.
Prostate Cancer and Prostatic Diseases|January 30, 2008
Sweet's syndrome in prostate cancerJ Glendenning, V Khoo
Breast (Edinburgh, Scotland)|October 22, 2011
PARP inhibitors--current status and the walk towards early breast cancerJennifer Glendenning, Andrew Tutt
The Medical Journal of Australia|April 3, 2004
8: Disorders of bone and mineral other than osteoporosisRichard L Prince, Paul Glendenning
Critical Reviews in Clinical Laboratory Sciences|September 18, 2015
Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementationPaul Glendenning, Charles A Inderjeeth
Internal Medicine Journal|January 11, 2002
Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significanceP Glendenning, S D Vasikaran
The Medical Journal of Australia|August 16, 2005
Fit for a fractureHannah M Seymour, Paul Glendenning
Pathology|July 12, 2002
Surgically correctable hypertensionPaul Glendenning, Samuel D Vasikaran
Acta Neurobiologiae Experimentalis|November 6, 1998
Lack of projections from medial geniculate body to suprasylvian cortex in cat: a study with horseradish peroxidaseM Stasiak, K K Glendenning
Internal Medicine Journal|October 11, 2012
What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?P Glendenning, R L Prince
Pageof 20